US 12,343,384 B2
Compositions for cosmetic and dermatological use
Serge Cappello, Tremblay en France (FR)
Assigned to SEMIOCARE SAS, Paris (FR)
Appl. No. 17/261,866
Filed by SEMIOCARE SAS, Paris (FR)
PCT Filed Jul. 19, 2019, PCT No. PCT/EP2019/069603
§ 371(c)(1), (2) Date Jan. 20, 2021,
PCT Pub. No. WO2020/016450, PCT Pub. Date Jan. 23, 2020.
Claims priority of application No. 1856756 (FR), filed on Jul. 20, 2018.
Prior Publication US 2021/0290737 A1, Sep. 23, 2021
Int. Cl. A61K 38/40 (2006.01); A61K 8/35 (2006.01); A61K 8/44 (2006.01); A61K 8/49 (2006.01); A61K 8/64 (2006.01); A61K 8/98 (2006.01); A61K 9/00 (2006.01); A61K 31/12 (2006.01); A61K 31/198 (2006.01); A61K 31/405 (2006.01); A61K 35/20 (2006.01); A61K 38/01 (2006.01); A61P 17/00 (2006.01); A61Q 19/08 (2006.01)
CPC A61K 38/40 (2013.01) [A61K 8/35 (2013.01); A61K 8/44 (2013.01); A61K 8/492 (2013.01); A61K 8/64 (2013.01); A61K 8/986 (2013.01); A61K 9/0014 (2013.01); A61K 31/12 (2013.01); A61K 31/198 (2013.01); A61K 31/405 (2013.01); A61K 35/20 (2013.01); A61K 38/018 (2013.01); A61P 17/00 (2018.01); A61Q 19/08 (2013.01); A61K 2800/522 (2013.01)] 18 Claims
 
1. A composition for topical application comprising lactoferrin, α-casozepine, and carboxymethylcellulose gel, wherein the weight ratio of lactoferrin to α-casozepine is from 0.1 to 6.